Home › Vertex to stop selling hepatitis C drug Incivek, once a blockbuster, in October
 

Keywords :   


Vertex to stop selling hepatitis C drug Incivek, once a blockbuster, in October

2014-08-13 07:02:43| Biotech - Topix.net

Incivek was the first approved drug for Vertex in 2011, but it was quickly overwhelmed by competition from other hepatitis C treatment, including Gilead's Sovaldi.

Tags: in october stop selling

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
15.05Voesh Unveils Body Refining Roller Crme Ahead of Summer 2024
15.05KANSAI HELIOS Completes Acquisition of WEILBURGER Coatings
15.05Portugal\'s Etifam adds Screen Truepress Label 350UV SAI-E
15.05Tom Hardy Is Jo Malone Londons New Ambassador for Cypress & Grapevine Cologne Intense
15.05Mooncat Introduces New Hue, Holds Bi-Annual Sale
15.05Eastern North Pacific Tropical Weather Outlook
More »